Sequential Administrations of a Vascular-Disrupting Agent, High-Intensity Focused Ultrasound, and a Radioactively labeled Necrosis Avid Compound for Eradicating Solid Malignancies

Radical treatment of malignant solid tumors should aim to be less traumatic, precise, and effective. OncoCiDia, as a noninvasive, sequential dual-targeting, small-molecule, broad spectrum anticancer theranostic approach, may fulfill these requirements of solid cancer (Onco) treatment with both tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yue, Wang, Shuncong, Chen, Lei, Feng, Yuanbo, Shen, Zhijun, Chen, Xin, Huang, Gang, Ni, Yicheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Novel Biomarkers, Molecular Diagnostics and Targeted Therapies of Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647265/
https://www.ncbi.nlm.nih.gov/pubmed/36344243
http://dx.doi.org/10.1177/15330338221136716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647265/
https://www.ncbi.nlm.nih.gov/pubmed/36344243
http://dx.doi.org/10.1177/15330338221136716

Ejemplares similares